Sotaglif lozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes Diabetes Care 2015;38:1181–1188 | DOI: 10.2337/dc14-2806 OBJECTIVE
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7097935125
